ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this ...

The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge ...

Continuous IVC geometry monitoring helps patients with heart failure identify congestion and manage care via a smartphone ...

Counterpart Health, Inc., a subsidiary of Clover Health, released research indicating that its AI-powered platform, Counterpart Assistant (CA), significantly improves the management of congestive ...

Key opinion leaders provide an overview of the treatment gaps in the management of heart failure. John McMurray, MBChB: Although I said that we have had many successes in the treatment of heart ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the ...

Know the key differences, early symptoms, causes and treatment options to avoid confusion and ensure timely medical care in ...

CHF combined with high SDOH burdens significantly increases all-cause and cardiovascular mortality risks. The study analyzed data from 38,947 participants, focusing on CHF and SDOH impacts on ...